Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.
Journal: Clinical genitourinary cancer
Published: November 30, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 18, 2020
Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma.
Journal: European urology
Published: May 19, 2020
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.
Journal: The Lancet. Oncology
Published: August 05, 2019
Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Journal: Journal of neurosurgery. Pediatrics
Published: December 18, 2012
The virtue of low-flow toilets.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 15, 2012
A proposed modification to the Best Pharmaceuticals for Children Act to benefit pediatric oncology.
Journal: Pediatric blood & cancer
Published: November 03, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026